The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening
- PMID: 32745173
- PMCID: PMC7936058
- DOI: 10.1093/jnci/djaa106
The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening
Comment on
-
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.J Natl Cancer Inst. 2021 Mar 1;113(3):292-300. doi: 10.1093/jnci/djaa105. J Natl Cancer Inst. 2021. PMID: 32745170 Free PMC article.
References
-
- Rossi PG, Carozzi F, Ronco G, et al. NTCC2 Working Group. p16/ki67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA positive women. J Natl Cancer Inst. 2020.
-
- Ronco G, Dillner J, Elfström KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524–532. - PubMed
-
- Polman NJ, Ebisch RMF, Heideman DAM, et al. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncol. 2019;20(2):229–238. - PubMed
-
- Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172–183. - PubMed
